DNA polymerase β deficiency is linked to aggressive breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts
- PMID: 24462520
- PMCID: PMC5528629
- DOI: 10.1016/j.molonc.2014.01.001
DNA polymerase β deficiency is linked to aggressive breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts
Abstract
Short arm of chromosome 8 is a hot spot for chromosomal breaks, losses and amplifications in breast cancer. Although such genetic changes may have phenotypic consequences, the identity of candidate gene(s) remains to be clearly defined. Pol β gene is localized to chromosome 8p12-p11 and encodes a key DNA base excision repair protein. Pol β may be a tumour suppressor and involved in breast cancer pathogenesis. We conducted the first and the largest study to comprehensively evaluate pol β in breast cancer. We investigated pol β gene copy number changes in two cohorts (n = 128 &n = 1952), pol β mRNA expression in two cohorts (n = 249 &n = 1952) and pol β protein expression in two cohorts (n = 1406 &n = 252). Artificial neural network analysis for pol β interacting genes was performed in 249 tumours. For mechanistic insights, pol β gene copy number changes, mRNA and protein levels were investigated together in 128 tumours and validated in 1952 tumours. Low pol β mRNA expression as well as low pol β protein expression was associated high grade, lymph node positivity, pleomorphism, triple negative, basal-like phenotypes and poor survival (ps < 0.001). In oestrogen receptor (ER) positive sub-group that received tamoxifen, low pol β protein remains associated with aggressive phenotype and poor survival (ps < 0.001). Artificial neural network analysis revealed ER as a top pol β interacting gene. Mechanistically, there was strong positive correlation between pol β gene copy number changes and pol β mRNA expression (p < 0.0000001) and between pol β mRNA and pol β protein expression (p < 0.0000001). This is the first study to provide evidence that pol β deficiency is linked to aggressive breast cancer and may have prognostic and predictive significance in patients.
Keywords: Breast cancer; Pol β; Predictive factor; Prognostic factor.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.Mol Oncol. 2014 Oct;8(7):1326-38. doi: 10.1016/j.molonc.2014.04.009. Epub 2014 May 13. Mol Oncol. 2014. PMID: 24880630 Free PMC article.
-
Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer.Breast Cancer Res Treat. 2014 Feb;143(3):411-21. doi: 10.1007/s10549-013-2820-7. Epub 2014 Jan 1. Breast Cancer Res Treat. 2014. PMID: 24381055
-
Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy.Breast Cancer Res Treat. 2013 Dec;142(3):515-27. doi: 10.1007/s10549-013-2769-6. Epub 2013 Nov 20. Breast Cancer Res Treat. 2013. PMID: 24253812
-
Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins.Mol Oncol. 2013 Jun;7(3):704-18. doi: 10.1016/j.molonc.2013.02.018. Epub 2013 Mar 19. Mol Oncol. 2013. PMID: 23562353 Free PMC article. Clinical Trial.
-
Is there a role for base excision repair in estrogen/estrogen receptor-driven breast cancers?Antioxid Redox Signal. 2014 Dec 1;21(16):2262-8. doi: 10.1089/ars.2014.6077. Epub 2014 Sep 22. Antioxid Redox Signal. 2014. PMID: 25111287 Free PMC article.
Cited by
-
_targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy.Mol Oncol. 2015 Jan;9(1):204-17. doi: 10.1016/j.molonc.2014.08.001. Epub 2014 Aug 27. Mol Oncol. 2015. PMID: 25205036 Free PMC article. Clinical Trial.
-
Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts.Neoplasia. 2014 Nov 20;16(11):982-91. doi: 10.1016/j.neo.2014.09.009. eCollection 2014 Nov. Neoplasia. 2014. PMID: 25425972 Free PMC article.
-
_targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy.Breast Cancer Res Treat. 2018 Jun;169(2):277-286. doi: 10.1007/s10549-018-4683-4. Epub 2018 Feb 2. Breast Cancer Res Treat. 2018. PMID: 29396668 Free PMC article.
-
Induced Fit in the Selection of Correct versus Incorrect Nucleotides by DNA Polymerase β.Biochemistry. 2016 Jan 19;55(2):382-95. doi: 10.1021/acs.biochem.5b01213. Epub 2015 Dec 30. Biochemistry. 2016. PMID: 26678253 Free PMC article.
-
The Emerging Role of PRMT6 in Cancer.Front Oncol. 2022 Mar 4;12:841381. doi: 10.3389/fonc.2022.841381. eCollection 2022. Front Oncol. 2022. PMID: 35311114 Free PMC article. Review.
References
-
- Albertella, M.R. , Lau, A. , O'Connor, M.J. , 2005. The overexpression of specialized DNA polymerases in cancer. DNA Repair. 4, 583–593. - PubMed
-
- Armes, J.E. , Hammet, F. , de Silva, M. , Ciciulla, J. , Ramus, S.J. , Soo, W.K. , Mahoney, A. , Yarovaya, N. , Henderson, M.A. , Gish, K. , Hutchins, A.M. , Price, G.R. , Venter, D.J. , 2004. Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers. Oncogene. 23, 5697–5702. - PubMed
-
- Blenkiron, C. , Goldstein, L.D. , Thorne, N.P. , Spiteri, I. , Chin, S.F. , Dunning, M.J. , Barbosa-Morais, N.L. , Teschendorff, A.E. , Green, A.R. , Ellis, I.O. , Tavare, S. , Caldas, C. , Miska, E.A. , 2007. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol.. 8, R214 - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous